United States Pharmacopeia (USP) acquires Pharmatech Associates
Scott-Macon's Healthcare Group Advises Pharmatech Associates on its sale to United States Pharmacopeia
July 2021
Scott-Macon, an investment bank specializing in mergers and acquisitions advisory services, has announced the sale of its client, Pharmatech Associates to United States Pharmacopeia (USP), an independent, scientific nonprofit organization. Pharmatech Associates is a global consultancy for the life science industry, meeting the complex needs of clients with highly experienced scientists and engineering subject matter experts. The transaction, led by Nate Cortright, extends the firm’s track record in the healthcare services sector.
“The USP and Pharmatech partnership is special, it represents USP’s first foray into consulting.” said Nate Cortright, a managing director and head of the Healthcare Group at Scott-Macon. “The partnership between the two businesses will create a next generation life science’s consultancy that will drive innovation.”
Pharmatech’s team specializes in product and process development, facilities and capital projects, quality compliance, and regulatory affairs. Pharmatech advises clients that range in size from startups to large multi-national corporations on projects in Asia, Europe, and North America from its headquarters in the San Francisco Bay Area.
USP is an independent, nonprofit, scientific organization that sets quality standards for medicines, dietary supplements, and food ingredients worldwide. USP’s quality standards are enforceable in the United States by the Food and Drug Administration and legally recognized in more than 50 countries. These standards, which are continuously developed and revised by more than 750 volunteer experts in science, industry, healthcare, and academia, are also used in more than 150 countries.
Scott-Macon, an independent investment bank, provides advisory services on mergers and acquisitions, valuation and debt and equity financing to businesses throughout the middle market. The firm leverages the expertise of its team to help clients achieve outcomes that support their objectives and further their strategic goals. Scott-Macon is committed to providing clients with thoughtful and objective advice and building meaningful, durable relationships. Scott-Macon Securities Inc. is a registered broker-dealer and member of FINRA and SIPC.
Scott-Macon’s Healthcare Group professionals have completed over 200 transactions across a variety of verticals, including medical devices, outsourced services, health care providers and tech-enabled services.
For more information on Scott-Macon’s Healthcare Group and other recent transactions, visit the Healthcare Group section of the Scott-Macon website. Contact Nate Cortright at , schedule a call, or call him any time on his mobile at (203) 246-6527 to discuss how Scott-Macon can assist you in achieving your business objectives.